β-cell function is associated with metabolic syndrome in Mexican subjects

References

• Lara-Esqueda A Meaney E Ceballos-Reyes GM Cardiovascular risk factors in urban female population of Mexico. The FRIMEX Study Rev Mex Cardiol 2007 18 24 34
   Google Scholar
• Eckel RH Grundy SM Zimmet PZ The metabolic syndrome Lancet 2005 365 1415 1428 15836891
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002 106 3143 3421 12485966
   PubMed Web of Science ®Google Scholar
• Hanley AJ Karter AJ Festa A Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the insulin resistance atherosclerosis study Diabetes 2002 51 2642 2647 12145182
   PubMed Web of Science ®Google Scholar
• Kahn SE Prigeon RL Schwartz RS Obesity, body fat distribution, insulin sensitivity and islet β-cell function as explanations for metabolic diversity J Nutr 2001 131 354S 360S 11160560
   PubMed Web of Science ®Google Scholar
• Weigensberg MJ Ball GDC Shaibi GQ Cruz ML Goran MI Decreased β-cell function in overweight latino children with impaired fasting glucose Diabetes Care 2005 28 2519 2524 16186290
   PubMed Web of Science ®Google Scholar
• Torrens JI Skurnick J Davidow AL Ethnic differences in insulin sensitivity and b-cell function in premonopausal or early perimenopausal women without diabetes Diabetes Care 2004 27 354 361 14747213
   PubMed Web of Science ®Google Scholar
• Saad MF Knowler WC Pettitt DJ Nelson RG Charles MA Bennett PH A two-step model for development of non-insulin dependent diabetes Am J Med 1991 90 229 235 1996593
   PubMed Web of Science ®Google Scholar
• Haffner SM Miettinen H Gaskill SP Stern MP Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans Diabetes 1995 44 1386 1391 7589843
   PubMed Web of Science ®Google Scholar
• Ministry of Health NORMA Oficial Mexicana NOM-030-1999-SSA2 for prevention, treatment and control of hypertension Mexico City, Mexico Ministry of Health 1999
   Google Scholar
• González-Chávez A Simental L Elizondo-Argueta S Sánchez-Zúñiga J Gutiérrez-Salgado G Guerrero-Romero F Prevalence of metabolic syndrome among non-diabetic Mexican adults, using the definitions of WHO, NCEP-ATPIIIa e IDF Rev Med Hosp Gen Mex 2008 71 11 19
   Google Scholar
• Hrebıcek J Janout V Malincikova J Horakova D Cizek L Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention J Clin Endocrinol Metab 2002 87 144 147 11788638
   PubMed Web of Science ®Google Scholar
• Mondan M Halkin H Lusky A Segal P Fuchs Z Chetrit A Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study Arterioscler Thromb Vasc Biol 1988 8 227 236
   Google Scholar
• Friedewald WT Kevy IR Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 1972 18 499 502 4337382
   PubMed Web of Science ®Google Scholar
• Boizel R Yves-Benhamou P Lardy B Laporte F Foulon T Halimi S Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels Diabetes Care 2000 23 1679 1685 11092292
   PubMed Web of Science ®Google Scholar
• Zimmet P Alberti GMM Serrano-Ríos M A new global definition of the metabolic syndrome proposed by the International Diabetes Federation: rationale and results Rev Esp Cardiol 2005 58 1371 1376 16371194
   PubMed Web of Science ®Google Scholar
• Saely CH Aczel S Marte T Langer P Hoefle G Drexel H The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients J Clin Endocrinol Metab 2005 90 5698 5703 16091486
   PubMed Web of Science ®Google Scholar
• Festa A Williams K D’Agostino RJr Wagenknecht LE Hffner SM The natural course of β cell function in nondiabetic and diabetic individuals Diabetes 2006 55 1114 1120 16567536
   PubMed Web of Science ®Google Scholar
• Arslanian SA Bacha F Saad R Gungor N Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth Diabetes Care 2005 28 127 131
   Web of Science ®Google Scholar
• Kahn SE Prigeon RL McCulloch DK Quantification of the relationship between insulin sensibility and B-cell function in human subjects. Evidence for a hyperbolic function Diabetes 1993 42 1663 1672 8405710
   PubMed Web of Science ®Google Scholar
• Kahn SE Beard JC Schwartz MW Increased b-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance Diabetes 1989 38 562 568 2653928
   PubMed Web of Science ®Google Scholar
• Dixon JB Dixon AF O’Brien PE Improvements in insulin sensitivity and b-cell function (HOMA) with weight loss in the severely obese Diabet Med 2003 20 127 134 12581264
   PubMed Web of Science ®Google Scholar
• Pimenta W Korytkowski M Mitrakou A Jenssen T Yki-Jarvinen H Evron W Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative JAMA 1995 273 1855 1861 7776502
   PubMed Web of Science ®Google Scholar
• Porte D Mechanisms for hyperglycemia in the metabolic syndrome. The key role of beta-cell dysfunction Ann NY Acad Sci 1999 892 73 83 10842653
   PubMed Web of Science ®Google Scholar
• Chiu KC Lee NP Cohan P Chuang LM Beta cell function declines with age in glucose tolerant caucasians Clin Endocrinol (Oxf) 2000 53 569 575 11106917
   PubMed Web of Science ®Google Scholar
• Cook JT Page RC Levy JC Hammersley MS Walravens EK Turner RC Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function Diabet Med 1993 10 321 326 8508613
   PubMed Web of Science ®Google Scholar
• Saltiel AR The molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases J Clin Invest 2000 106 163 164 10903328
   PubMed Web of Science ®Google Scholar
• Katz A Nambi SS Mather K Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 2000 85 2402 2410 10902785
   PubMed Web of Science ®Google Scholar
• Muniyappa R Lee S Chen H Quon MJ Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 2008 294 E15 E26 17957034
   PubMed Web of Science ®Google Scholar
• Chen H Sullivan G Yue LQ Katz A Quon MJ QUICKI is a useful index of insulin sensitivity in subjects with hypertension Am J Physiol Endocrinol Metab 2003 284 E804 E812 12678026
   PubMed Web of Science ®Google Scholar
• García-Cuartero B García-Lacalle C Jiménez-Lobo C Índice HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular An Pediatr (Barc) 2007 66 481 490 17517203
   PubMedGoogle Scholar
• Sarafidis PA Lasaridis AN Nilsson PM Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley’s indices in patients with hypertension and type II diabetes. Surrogates of insulin sensitivity in hypertension J Hum Hypertens 2007 21 709 716 17443211
   PubMed Web of Science ®Google Scholar
• Chen H Sullivan G Quon MJ Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model Diabetes 2005 54 1914 1925 15983190
   PubMed Web of Science ®Google Scholar
• Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985 28 412 419 3899825
   PubMed Web of Science ®Google Scholar
• Turner RC Rudenski AS Mathews DR Levy JC O’Rahilly SP Hosker JP Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity Horm Metab Res Suppl 1990 24 66 71 2272629
   PubMedGoogle Scholar
• Haffner SM Miettinen H Stern MP The homeostasis model in the San Antonio Heart Study Diabetes Care 1997 20 1087 1092 9203442
   PubMed Web of Science ®Google Scholar
• Song Y Manson JE Tinker L Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women’s Health Initiative Observational Study Diabetes Care 2007 30 1747 1752 17468352
   PubMed Web of Science ®Google Scholar